Delivery Order SPE2DB25D3201-SPE2DB25FNTFD

Award Date 5/15/25
Potential Completion Date 5/16/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $14,387.90 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of ACTEMRA 400 MG/20 ML VIAL 20ML, a pharmaceutical product, with an ultimate completion date of October 31, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML, a pharmaceutical product, and has a ceiling value of $3,297.92. The contract is a firm fixed price, delivery order contract with a completion date of March 25, 2025. The contract was not awarded under any set-aside program. Amerisourcebergen Drug Corp is the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,008.46, is for the supply of ACTEMRA 200 MG/10 ML VIAL 10ML, a specialty medication. The contract has a firm fixed price pricing type and a completion date of November 24, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML, a specialty medication, with a ceiling value of $19,787.52 and a period of performance through February 10, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds...
This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML, a pharmaceutical product, with a ceiling value of $30,179.46. The contract is a firm fixed price delivery order with a period of performance through February 19, 2025. This award is part of a larger Indefinite Delivery...
This is a $13,191.68 firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML. The contract has an ultimate completion date of May 19, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle with a...
This is a $45,862.39 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,566,364,937 units of ACTEMRA 400 MG/20 ML VIAL 20ML, a specialty medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4,565,230,600 units of the pharmaceutical product Actemra 200 mg/10 ml vial. The contract has a ceiling value of $13,156.06 and a period of performance through July 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML. The delivery order is valued at $24,985.62 and has a firm fixed price contract type. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty medication. The contract has a ceiling value of $13,310.37 and runs through January 9, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA,...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNTFD
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ACTEMRA 400 MG/20 ML VIAL 20ML, a pharmaceutical product, with a ceiling value of $12,381.40. The contract has a firm fixed price pricing type and a period of performance through May 16, 2025. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) vehicle held by AmerisourceBergen Drug Corp with the DLA, valued at $999,999,999.00, which provides comprehensive global pharmaceutical support to military healthcare programs. The contract is not designated as a set-aside.

Generated 8/17/25, 1:24 AM